Matthew B. Klein, Officer, Director: PTC Therapeutics PTCT Planned sale · Filed 25/02/20

Trade details

Type: Planned sale notice
Stock: PTC Therapeutics PTCT
Person: Matthew B. KleinOfficer, Director
Planned sale date: 25/02/20
Filed: 25/02/20

More to sell after $773.1K in 3 months

PTC Therapeutics trades, last 26 weeks

What else happened in PTC Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/21~25/03/22

Matthew B. Klein's recent trades

Matthew B. KleinOfficer, Director
Planned salePTC Therapeutics
Planned sale
PTC Therapeutics
PTCT
$705.8K
10,292 sh
$705.8K
Filed 08/04
Traded 08/04
Matthew B. KleinDirector
SellClearPoint Neuro
Sell
ClearPoint Neuro
CLPT
$185.4K
16,000 sh
$185.4K
Filed 05/26
Traded 05/21
Matthew B. KleinDirector
Planned saleClearPoint Neuro
Planned sale
ClearPoint Neuro
CLPT
$185.4K
16,000 sh
$185.4K
Filed 05/21
Traded 05/21
Matthew B. KleinCEO
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 plan
PTC Therapeutics
PTCT
$527.7K
7,221 sh
$527.7K
Filed 05/15
Traded 05/14
Matthew B. KleinCEO
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 plan
PTC Therapeutics
PTCT
$186.4K
2,572 sh
$186.4K
Filed 05/15
Traded 05/14

Matthew B. Klein, Director — plans to sell 3,895 sh of PTC Therapeutics PTCT · $195.2K · around 02/20 | Whalegun